首站-论文投稿智能助手
典型文献
Site-selective oral delivery of therapeutic antibodies to the inflamed colon via a folic acid-grafted organic/inorganic hybrid nanocomposite system
文献摘要:
This study aimed to develop a pH-responsive folic acid-grafted organic/inorganic hybrid na-nocomposite system for site-selective oral delivery of therapeutic antibodies.A folic acid-grafted amino-clay(FA-AC)was prepared via an in situ sol-gel method.Then,a drug-loaded nanocomplex was prepared via the electrostatic interaction of FA-AC with infliximab(IFX),a model antibody,and coated with Eudragit? S100(EFA-AC-IFX).FA-AC exhibited favorable profiles as a drug carrier including low cytotoxicity,good target selectivity,and capability to form a nanocomplex with negatively charged mac-romolecules.A pH-responsive FA-AC-based nanocomplex containing IFX(EFA-AC-IFX)was also ob-tained in a narrow size distribution with high entrapment efficiency(>87%).The conformational stability of IFX entrapped in EFA-AC-IFX was well maintained in the presence of proteolytic enzymes.EFA-AC-IFX exhibited pH-dependent drug release,minimizing premature drug release in gastric conditions and the upper intestine.Accordingly,oral administration of EFA-AC-IFX to colitis-induced mice was effec-tive in alleviating the progression of ulcerative colitis,while oral IFX solution had no efficacy.These re-sults suggest that a pH-responsive FA-AC-based nanocomposite system can be a new platform for the site-selective oral delivery of therapeutic antibodies.
文献关键词:
作者姓名:
Sang Hoon Lee;Jae Geun Song;Hyo-Kyung Han
作者机构:
College of Pharmacy,Dongguk University-Seoul,Goyang 10326,South Korea
引用格式:
[1]Sang Hoon Lee;Jae Geun Song;Hyo-Kyung Han-.Site-selective oral delivery of therapeutic antibodies to the inflamed colon via a folic acid-grafted organic/inorganic hybrid nanocomposite system)[J].药学学报(英文版),2022(11):4249-4261
A类:
nocomposite,nanocomplex,romolecules
B类:
Site,selective,oral,delivery,therapeutic,antibodies,inflamed,colon,folic,acid,grafted,inorganic,hybrid,nanocomposite,system,This,study,aimed,develop,responsive,amino,clay,AC,was,prepared,situ,gel,method,Then,drug,loaded,electrostatic,interaction,infliximab,IFX,model,antibody,coated,Eudragit,S100,EFA,exhibited,favorable,profiles,carrier,including,low,cytotoxicity,good,target,selectivity,capability,negatively,charged,mac,containing,also,ob,narrow,size,distribution,high,entrapment,efficiency,conformational,stability,entrapped,well,maintained,presence,proteolytic,enzymes,dependent,release,minimizing,premature,gastric,conditions,upper,intestine,Accordingly,administration,colitis,induced,mice,effec,alleviating,progression,ulcerative,while,solution,had,efficacy,These,sults,suggest,that,can,be,new,platform
AB值:
0.500716
相似文献
The complexation of insulin with sodium N-[8-(2-hydroxybenzoyl)amino]-caprylate for enhanced oral delivery:Effects of concentration,ratio,and pH
Huixian Weng;Lefei Hu;Lei Hu;Yihan Zhou;Aohua Wang;Ning Wang;Wenzhe Li;Chunliu Zhu;Shiyan Guo;Miaorong Yu;Yong Gan-School of Chinese Materia Medica,Nanjing University of Chinese Medicine,Nanjing 210046,China;State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;School of Pharmacy,Nanjing University of Chinese Medicine,Nanjing 210023,China;Nano Science and Technology Institute,University of Science and Technology of China,Nanjing 215123,China;University of Chinese Academy of Sciences,Beijing 100049,China;NMPA Key Laboratory for Quality Research and Evaluation of Pharmaceutical Excipients,National Institutes for Food and Drug Control,Beijing 100050,China
Targeting the Rac1 pathway for improved prostate cancer therapy using polymeric nanoparticles to deliver of NSC23766
Zean Li;Jun Huang;Tao Du;Yiming Lai;Kaiwen Li;Man-Li Luo;Dingjun Zhu;Jun Wu;Hai Huang-Department of Urology,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510220,China;Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510120,China;Medical Research Center,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510120,China;School of Biomedical Engineering,Sun Yat-sen University,Shenzhen 518107,China;Department of Obstetrics and Gynecology,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510120,China;Department of Urology,The Sixth Affiliated Hospital of Guangzhou Medical University,Qingyuan People's Hospital,Qingyuan 511518,China
Rapid fabrication of zwitterionic sulfobetaine vinylimidazole-based monoliths via photoinitiated copolymerization for hydrophilic interaction chromatography
Qiqin Wang;Lingjue Sun;Huihui Wu;Ning Deng;Xianglong Zhao;Jingwei Zhou;Tingting Zhang;Hai Han;Zhengjin Jiang-Institute of Pharmaceutical Analysis,College of Pharmacy,Jinan University,Guangzhou,510632,China;Anhui Prevention and Treatment Center for Occupational Disease,Anhui No.2 Provincial People's Hospital,Hefei,230041,China;Key Laboratory of Environment-Friendly Chemistry and Application of Ministry of Education,Lab of Biochemistry,College of Chemistry,Xiangtan University,Xiangtan,Hunan,411105,China;Department of Pharmacy and Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine&New Drug Research,Jinan University,Guangzhou,510632,China
Nasal delivery of broadly neutralizing antibodies protects mice from lethal challenge with SARS-CoV-2 delta and omicron variants
Jia Lu;Qiangling Yin;Rongjuan Pei;Qiu Zhang;Yuanyuan Qu;Yongbing Pan;Lina Sun;Ding Gao;Cuiqin Liang;Jingwen Yang;Wei Wu;Jiandong Li;Zongqiang Cui;Zejun Wang;Xinguo Li;Dexin Li;Shiwen Wang;Kai Duan;Wuxiang Guan;Mifang Lian;Xiaoming Yang-National Engineering Technology Research Center for Combined Vaccines,Wuhan Institute of Biological Products Co.Ltd.,Wuhan,430070,China;State Key Laboratory for Molecular Virology and Genetic Engineering National Institute for Viral Disease Control and Prevention,Chinese Center for Disease Control and Prevention,Beijing,102206,China;Center for Emerging Infectious Diseases,Wuhan Institute of Virology,Chinese Academy of Sciences,Wuhan,430071,China;CDC-WIV Joint Research Center for Emerging Diseases and Biosafety,Wuhan,430071,China;Institution of Infectious Diseases,Shenzhen Bay Laboratory,Shenzhen,518107,China
Pharmacodynamic,pharmacokinetic,and phase 1a study of bisthianostat,a novel histone deacetylase inhibitor,for the treatment of relapsed or refractory multiple myeloma
Yu-bo Zhou;Yang-ming Zhang;Hong-hui Huang;Li-jing Shen;Xiao-feng Han;Xiao-bei Hu;Song-da Yu;An-hui Gao;Li Sheng;Ming-bo Su;Xiao-li Wei;Yue Zhang;Yi-fan Zhang;Zhi-wei Gao;Xiao-yan Chen;Fa-jun Nan;Jia Li;Jian Hou-National Center for New Drug Screening,State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;University of Chinese Academy of Sciences,Beijing 100049,China;Yantai Key Laboratory of Nanomedicine&Advanced Preparations,Yantai Institute of Materia Medica,Yantai 264000,China;Department of Hematology,Renji Hospital,Shanghai Jiaotong University School of Medicine,Shanghai 200127,China;Shanghai Center for Drug Metabolism and Pharmacokinetics Research,Shanghai 201203,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。